Cargando…
Rethinking the management of immune checkpoint inhibitor‐related adrenal insufficiency in cancer patients during the COVID‐19 pandemic
INTRODUCTION: The coronavirus disease 2019 (COVID‐19) is currently a major pandemic challenge, and cancer patients are at a heightened risk of severity and mortality from this infection. In recent years, immune checkpoint inhibitor (ICI) use to treat multiple cancers has increased in oncology, but e...
Autores principales: | Yuen, Kevin C. J., Mortensen, Michael J., Azadi, Amir, Fonkem, Ekokobe, Findling, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250331/ https://www.ncbi.nlm.nih.gov/pubmed/34268454 http://dx.doi.org/10.1002/edm2.246 |
Ejemplares similares
-
PSAT042 Adrenal Insufficiency Associated to Immune Checkpoint Inhibitors
por: Barreto, Brigida Colon, et al.
Publicado: (2022) -
COVD-14. TELEMEDICINE REVIEW IN NEURO-ONCOLOGY: COMPARATIVE EXPERIENTIAL ANALYSIS FOR BARROW NEUROLOGICAL INSTITUTE AND GEISINGER HEALTH DURING THE 2020 COVID-19 PANDEMIC
por: Fonkem, Ekokobe, et al.
Publicado: (2020) -
Adrenal Insufficiency Masquerading as Primary Hypothyroidism Following Immune Checkpoint Inhibitors Treatment
por: Salim, Michael, et al.
Publicado: (2021) -
FRI257 Adrenal Insufficiency Secundary Due Immune Checkpoint Inhibitors Therapy
por: Rivera, Sandra Rocio, et al.
Publicado: (2023) -
A Rare Case of Burkitt’s Lymphoma Presenting With Features Mimicking Vogt-Koyanagi-Harada Disease
por: Tadipatri, Ramya, et al.
Publicado: (2021)